BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21328336)

  • 1. Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells.
    Schüler Y; Lee-Thedieck C; Geiger K; Kaiser T; Ino Y; Aicher WK; Klein G
    Int J Cancer; 2012 Jan; 130(2):288-99. PubMed ID: 21328336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.
    Nam JS; Kang MJ; Suchar AM; Shimamura T; Kohn EA; Michalowska AM; Jordan VC; Hirohashi S; Wakefield LM
    Cancer Res; 2006 Jul; 66(14):7176-84. PubMed ID: 16849564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
    Pan T; Lin SC; Yu KJ; Yu G; Song JH; Lewis VO; Bird JE; Moon B; Lin PP; Tannir NM; Jonasch E; Wood CG; Gallick GE; Yu-Lee LY; Lin SH; Satcher RL
    Neoplasia; 2018 Jan; 20(1):32-43. PubMed ID: 29190493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
    Wang H; Qu Y; Dai B; Zhu Y; Shi G; Zhu Y; Shen Y; Zhang H; Ye D
    PLoS One; 2017; 12(8):e0180862. PubMed ID: 28846693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis.
    Kominsky SL; Abdelmagid SM; Doucet M; Brady K; Weber KL
    Cancer Res; 2008 Mar; 68(5):1261-6. PubMed ID: 18316587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma.
    Wang J; You H; Qi J; Yang C; Ren Y; Cheng H
    Oncotarget; 2017 Mar; 8(10):17012-17026. PubMed ID: 28199984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.
    Sun KH; Sun GH; Wu YC; Ko BJ; Hsu HT; Wu ST
    J Cell Mol Med; 2016 Nov; 20(11):2020-2028. PubMed ID: 27297979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
    Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
    Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells.
    Shimamura T; Yasuda J; Ino Y; Gotoh M; Tsuchiya A; Nakajima A; Sakamoto M; Kanai Y; Hirohashi S
    Cancer Res; 2004 Oct; 64(19):6989-95. PubMed ID: 15466191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells.
    Menon LG; Picinich S; Koneru R; Gao H; Lin SY; Koneru M; Mayer-Kuckuk P; Glod J; Banerjee D
    Stem Cells; 2007 Feb; 25(2):520-8. PubMed ID: 17053212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
    Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
    Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cancer secretome induces migration of mesenchymal stromal cells.
    Popławski P; Zarychta-Wiśniewska W; Burdzińska A; Bogusławska J; Adamiok-Ostrowska A; Hanusek K; Rybicka B; Białas A; Kossowska H; Iwanicka-Rokicka R; Koblowska M; Pączek L; Piekiełko-Witkowska A
    Stem Cell Res Ther; 2023 Aug; 14(1):200. PubMed ID: 37563650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases.
    Perut F; Cenni E; Unger RE; Kirkpatrick CJ; Giunti A; Baldini N
    Int J Oncol; 2009 May; 34(5):1387-93. PubMed ID: 19360351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
    Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
    Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma-adjacent tissues enhance mobilization and recruitment of endothelial progenitor cells to promote the invasion of the neoplasm.
    Zhao Y; Yu P; Wu R; Ge Y; Wu J; Zhu J; Jia R
    Biomed Pharmacother; 2013 Sep; 67(7):643-9. PubMed ID: 23910158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis.
    Sharma U; Pal D; Singh SK; Kakkar N; Prasad R
    Biochimie; 2014 Sep; 104():27-35. PubMed ID: 24909115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
    Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
    Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.